Nifty 17401.65 (1.37%)
Sensex 58461.29 (1.35%)
Nifty Bank 36508.25 (0.39%)
Nifty IT 36157.85 (2.06%)
Nifty Financial Services 17982.9 (1.26%)
Adani Ports 739.10 (4.40%)
Asian Paints 3180.60 (1.35%)
Axis Bank 676.10 (-0.52%)
B P C L 378.85 (2.74%)
Bajaj Auto 3328.40 (2.43%)
Bajaj Finance 7180.50 (2.01%)
Bajaj Finserv 17758.15 (2.16%)
Bharti Airtel 732.55 (1.43%)
Britannia Inds. 3578.50 (1.22%)
Cipla 921.25 (-0.74%)
Coal India 159.30 (2.41%)
Divis Lab. 4777.30 (0.53%)
Dr Reddys Labs 4662.75 (1.22%)
Eicher Motors 2451.55 (0.54%)
Grasim Inds 1723.85 (2.63%)
H D F C 2807.80 (3.85%)
HCL Technologies 1184.70 (2.42%)
HDFC Bank 1525.75 (1.40%)
HDFC Life Insur. 705.30 (1.65%)
Hero Motocorp 2472.70 (1.00%)
Hind. Unilever 2383.30 (1.64%)
Hindalco Inds. 432.10 (1.69%)
I O C L 120.65 (2.51%)
ICICI Bank 722.40 (-0.73%)
IndusInd Bank 945.55 (1.27%)
Infosys 1748.25 (1.94%)
ITC 225.45 (1.60%)
JSW Steel 646.75 (1.50%)
Kotak Mah. Bank 1964.25 (0.56%)
Larsen & Toubro 1789.20 (0.18%)
M & M 849.55 (1.78%)
Maruti Suzuki 7324.95 (0.71%)
Nestle India 19503.20 (0.54%)
NTPC 128.70 (0.78%)
O N G C 144.00 (1.23%)
Power Grid Corpn 214.50 (3.52%)
Reliance Industr 2482.85 (0.64%)
SBI Life Insuran 1188.05 (1.99%)
Shree Cement 26289.80 (0.76%)
St Bk of India 477.00 (0.36%)
Sun Pharma.Inds. 766.25 (2.80%)
Tata Consumer 773.25 (0.06%)
Tata Motors 479.10 (0.81%)
Tata Steel 1112.40 (2.76%)
TCS 3642.90 (1.82%)
Tech Mahindra 1629.65 (2.65%)
Titan Company 2386.50 (1.11%)
UltraTech Cem. 7323.20 (0.01%)
UPL 698.20 (1.12%)
Wipro 646.80 (1.89%)
INFY

Procter & Gamble Health L..

₹5298.05
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD P & G Health Ltd

  • Master Rating:
  • Procter & Gamble Health has an operating revenue of Rs. 1,017.56 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of 23% is great, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Procter & Gamble Health Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Procter & Gamble Health Ltd Synopsis

NSE-Medical-Generic Drugs

P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1008.73 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2021. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
  • Market Cap

    INR 8,794.23 Cr

  • Sales

    INR 1,017.56 Cr

  • Shares in Float

    0.80 Cr

  • No of Funds

    104 K

  • Yield

    0.75%

  • Book Value

    12.5

  • U/D Vol Ratio

    0.9

  • LTDebt/Equity

    %

  • Alpha

    -0.14

  • Beta

    0.4

Procter & Gamble Health Ltd Ownership
Procter & Gamble Health Ltd Management

Procter & Gamble Health Ltd Financials

INDICATORJun 2021Jun 2020Dec 2019Dec 2018Dec 2017
Total ShareHolders Funds Annual Cr 703.71906.34816.8141540.11733.26
Fixed Assets Annual Cr 143.06122.67112.446120.93123.97
Total Non Current Assets Annual Cr 259.02219.55221.277225.16238.89
Total Current Assets Annual Cr 727.14956.19845.4041534.3746.11
Total Assets Annual Cr 986.161175.741066.6811759.46991.22
INDICATORJun 2021Jun 2020Dec 2019Dec 2018Dec 2017
Book Value Per Share Annual Rs 423.921545.987927.777441.722
ROE Annual % 25.1228.0354.4512.8
ROCE Annual % 31.3237.419.6817.64
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 26.1828.3427.1420.3216.19

Procter & Gamble Health Ltd Technicals

EMA & SMA

CURRENT PRICE

5298.05 (-0.76)

    • Bullish Moving Averages 9
    • Bearish Moving Averages 7

EMA

  • 20 Day

    5204.99

  • 50 Day

    5325.05

  • 100 Day

    5489.65

  • 200 Day

    5838.13

Procter & Gamble Health Ltd Resistance and support

5313.77 PIVOT

  • First Resistance

    5394.84

  • Second Resistance

    5451.02

  • Third Resistance

    5532.09

  • First Support

    5257.59

  • Second Support

    5176.52

  • Third Support

    5120.34

  • RSI

    53.76

  • MFI

    55.84

  • MACD

    -60.44

  • MACD signal line

    -96.97

Procter & Gamble Health Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,494 225,913 50.27%
Week 15,209 880,613 57.9%
1 Month 10,619 650,745 61.28%
6 Month 13,244 878,470 66.33%

Procter & Gamble Health Ltd Price change analysis

-75.8

Over 1 month

Low High
4903 5490

-31.85

Over 3 month

Low High
4903 5851.75

-586

Over 6 months

Low High
4903 5934.05

-1469.25

Over Year

Low High
4903 7500

Similar Stocks

News

Wall St bounces back after rout spurred by inflation, Omicro

Merck & Co Inc gained 1.8% after a panel of advisers to the U.S. Food and Drug Administration narrowly voted to recommend the agency authori Read More

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (

Pursuant to regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015,we hereby inform you regarding is Read More

Procter & Gamble Health Ltd - 500126 - Announcement- Addendu

We would like to submit an addendum to the notice of the Postal Ballot along with Postal Ballot form with respect to the Company's proposal Read More

Procter & Gamble Health Ltd - 500126 - Shareholder Meeting /

We would like to submit the notice of the Postal Ballot along with Postal Ballot form with respect to Company''s proposal for seeking member Read More

Merck says its antiviral pill less effective in final analys

The lower efficacy is a disappointment for the drug, known as molnupiravir, which health officials around the world are counting on as a cri Read More

Blogs

FAQs